Author:
Weiss H. Markus,Umehara Ken-Ichi,Erpenbeck Veit J.,Cain Meredith,Vemula Janardhana,Elbast Walid,Zollinger Markus
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference25 articles.
1. Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids;Bateman;Eur Respir J,2017
2. Simultaneous oral therapeutic and intravenous 14C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin;Boulton;Br J Clin Pharmacol,2013
3. Concomitant oral and intravenous pharmacokinetics of dabrafenib, a BRAF inhibitor, in patients with BRAF V600 mutation-positive solid tumors;Denton;J Clin Pharmacol,2013
4. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4
5. Fevipiprant (QAW039) demonstrates safety, tolerability and consistent PK at high oral doses;Erpenbeck;Eur Respir J,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献